- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: MUC1.
Displaying page 1 of 1.
EudraCT Number: 2011-000218-20 | Sponsor Protocol Number: LICC01 | Start Date*: 2011-09-21 | |||||||||||
Sponsor Name:Universitätsmedizin Mainz | |||||||||||||
Full Title: LICC: L-BLP25 in Patients with Colorectal Carcinoma after curative resection of hepatic metastases – a randomized, placebo-controlled, multicenter, multinational, double blinded phase II trial | |||||||||||||
Medical condition: Patients with metastatic colorectal carcinoma (CRC), who have undergone a complete resection of their primary tumor and recent resection of their liver metastases (R0 or R1) with curative intent. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000847-25 | Sponsor Protocol Number: EMR63325-013 | Start Date*: 2011-07-04 | |||||||||||
Sponsor Name:Merck KGaA | |||||||||||||
Full Title: A multi-center, randomized, open-label, mechanism of action trial on the biological effects of the therapeutic cancer vaccine Stimuvax® (L-BLP25) in rectal cancer subjects undergoing neoadjuvant ch... | |||||||||||||
Medical condition: Rectal cancer subjects undergoing neoadjuvant chemoradiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) PT (Completed) DE (Completed) NL (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004467-31 | Sponsor Protocol Number: DECENDO | Start Date*: 2019-04-05 |
Sponsor Name: | ||
Full Title: An exploratory study: Dendritic cells for immunotherapy of metastatic endometrial cancer patients | ||
Medical condition: metastatic endometrial cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001015-22 | Sponsor Protocol Number: TG4010.09 | Start Date*: 2006-03-02 |
Sponsor Name:TRANSGENE | ||
Full Title: A Phase IIb Multicentric Controlled Study Evaluating the Therapeutic Vaccine TG4010 (MVA-MUC1-IL2) as an Adjunct to Standard Chemotherapy in Advanced Non Small Cell Lung Cancer | ||
Medical condition: Advanced Non Small Cell Lung Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) DE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006287-50 | Sponsor Protocol Number: EMAOS | Start Date*: 2015-04-01 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Phase III comparative clinical trial to evaluate the efficacy of amniotic membrane extract for the treatment of severe dry eye disease, in comparison with autologous serum eyedrops. | |||||||||||||
Medical condition: Severe Dry Eye Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014869-43 | Sponsor Protocol Number: 2008_47/0928 | Start Date*: 2009-12-21 | |||||||||||
Sponsor Name:Centre Hospitalier Régional et Universitaire | |||||||||||||
Full Title: Influence des acides gras polyinsaturés à longue chaîne n-3 sur l'expression des mucines dans la muqueuse nasale de patients atteints de mucoviscidose | |||||||||||||
Medical condition: Mucoviscidose | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001468-23 | Sponsor Protocol Number: TG4010.14 | Start Date*: 2011-12-19 | ||||||||||||||||
Sponsor Name:Transgene S.A. | ||||||||||||||||||
Full Title: A Phase IIb/III randomized, double-blind, placebo-controlled study comparing first-line therapy with or without TG4010 immunotherapy product in patients with stage IV non-small cell lung cancer (NS... | ||||||||||||||||||
Medical condition: Stage IV non small cell lung cancer (NSCLC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) HU (Completed) GB (Completed) DE (Prematurely Ended) ES (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
